Skip to main content

Table 2 Blood pressures, Blood biochemical parameters, Lipid and protein oxidative products, Sodium excretion rate, and HBMD in people with treated T2D before (baseline) and after treatment (24-week) within the Main (Experimental) and Control (Conventional) groups (M ± SEM)

From: Weight loss technology for people with treated type 2 diabetes: a randomized controlled trial

Variables

Main group, n = 208

Control group, n = 64

Baseline

24-week

Baseline

24-week

Systolic blood pressure (mmHg)

154.3 ± 1.22

120.4 ± 0.67**

150.4 ± 1.76

128.7 ± 2.17**

Diastolic blood pressure (mmHg)

98.7 ± 0.75

80.92 ± 0.63**

98.1 ± 0.98

93.2 ± 1.29*

Hemoglobin (g/L)

126.5 ± 0.68

138.9 ± 0.62**

127.1 ± 0.71

127.4 ± 0.72

ESR (mm/Hour)

23.4 ± 0.64

7.66 ± 0.26**

22.9 ± 0.70

24.8 ± 0.75*

Eosinophilia (%)

5.35 ± 0.21

1.82 ± 0.14**

5.29 ± 0.29

6.08 ± 0.30*

Glucose (mmol/L)

8.64 ± 0.19

4.50 ± 0.11**

8.58 ± 0.24

6.04 ± 0.21**

2-hour OGTT (mmol/L)

14.5 ± 0.28

6.7 ± 0.19**

14.1 ± 0.33

8.21 ± 0.42**

HbA1c (mmol/mol and %)

52.0 ± 0.68 (6.91 ± 0.09)

35.0 ± 0.52** (5.39 ± 0.08)

52.0 ± 1.13 (6.89 ± 0.15)

46.0 ± 1.15* (6.38 ± 0.16)

Cholesterol (mmol/L)

5.82 ± 0.07

4.54 ± 0.05**

5.77 ± 0.09

5.47 ± 0.11*

Triglyceride (g/L)

2.42 ± 0.08

0.81 ± 0.05**

2.21 ± 0.08

1.92 ± 0.12*

Total Fibrinogen (g/L)

4.52 ± 0.07

2.21 ± 0.06**

4.58 ± 0.09

4.05 ± 0.18*

MDA (μmol/L)

48.47 ± 0.68

33.48 ± 0.29**

46.99 ± 0.75

50.46 ± 0.79*

SOD (U/mg)

53.83 ± 0.54

77.71 ± 0.67**

52.91 ± 0.65

56.87 ± 0.97*

Catalase (U/g)

22.17 ± 0.42

26.44 ± 0.46**

23.81 ± 0.49

25.17 ± 0.68

AOPP (μmol/L)

266.8 ± 12.6

181.8 ± 7.8**

262.4 ± 13.6

295.6 ± 13.9*

Sodium in the urine (mmol/L)

164.1 ± 2.8

32.4 ± 1.9**

164.1 ± 2.8

182.4 ± 3.5**

Sodium in the blood (mmol/L)

134.4 ± 0.32

143.7 ± 0.38**

135.1 ± 0.35

134.1 ± 0.34*

HBMD (Units)

77.83 ± 1.86

93.2 ± 1.37**

78.78 ± 1.92

76.87 ± 1.88

  1. Abbreviations: ANADET analimentary detoxication, AOPP advanced oxidation protein products, ESR erythrocyte sedimentation rate, HBMD heel bone mineral density, M mean, MDA malondialdehyde, OGTT oral glucose tolerance test, SOD superoxide dismutase, SEM standard error of the mean, T2D type 2 diabetes
  2. *P-value of < 0.05, and
  3. **P < 0.0001 were set as significant between baseline and 24-week treatment within group comparison